Investigating innovative treatment approaches for metastatic breast cancer, specifically focusing on patients with hormone receptor-positive and HER2-negative disease. The research explores the potential benefits of treatment modification strategies.

Treatment Optimization Studies
Long-term Disease Management
Hormone Receptor-Positive Cancer

Current trials are evaluating the effectiveness of discontinuing specific treatments in patients who have shown sustained positive response, with the goal of improving quality of life while maintaining disease control.

Back to Germany All countries

Clinical trials in Gerlingen

1 trial in Gerlingen

Hormone receptor positive breast cancer+1

Study on Stopping CDK4/6 Inhibitors in Patients with Metastatic HR Positive, HER2 Negative Breast Cancer Using Abemaciclib, Letrozole, and Fulvestrant

Filter the trials

Other cities in Germany

Clinical research in Gerlingen

Prefer not to search? Our Concierge searches the trials for you.